BAX Chart

1 Month

	Date	Diff
	2023-11-30	-0.88 %
The article is not related to Baxter International (BAX) stock going down. It is about DaVita's successful fundraising event called Move It With Purpose, which raised over $750,000 for the nonprofit organization Bridge of Life. Baxter International Inc. stock went down by 0.08% due to underperformance compared to its competitors, including Medtronic PLC, Stryker Corp., and Becton Dickinson & Co.
	2023-11-28	-0.22 %
The article announces a partnership between Baxter International Foundation and UNICEF to improve access to safe drinking water and sanitation in Egypt; the stock went down due to unrelated factors.
	2023-11-21	+0.22 %
Baxter International (BAX) stock went up 0.22% due to positive market performance, despite a rough trading session overall; it was the seventh consecutive day of gains for the stock.
	2023-11-15	+2.79 %
The stock of Baxter International Inc. (BAX) rose by 2.79% due to a favorable trading session in the stock market, with the S&P 500 Index and the Dow Jones Industrial Average also rising. The stock outperformed some of its competitors, including Medtronic PLC, Stryker Corp, and Becton Dickinson & Co. Trading volume was higher than the 50-day average volume.
	2023-11-14	+1.9 %
The article announces that Baxter International Inc. has declared a quarterly cash dividend of $0.29 per share of common stock, which has likely led to the increase in Baxter International (BAX) stock.
	2023-11-10	-0.03 %
In its third quarter 2023 earnings call, CytoSorbents Corporation reported a 20% increase in product sales compared to the previous year, announced its ongoing partnership with Fresenius Medical Care to market its blood purification therapy, and noted progress on the development of the DrugSorb-ART antithrombotic removal system. The stock of CytoSorbents has been experiencing a significant decline over the past week due to the company burning through cash and negative projections for profitability this year.
	2023-11-09	-3.58 %
The stock of Baxter International Inc. (BAX) went down by 3.58% due to an overall dismal trading session in the stock market, with the S&P 500 Index and Dow Jones Industrial Average also experiencing declines. The stock's performance was compared to some of its competitors, including Medtronic PLC, Stryker Corp., and Becton Dickinson & Co., which also saw decreases in their stock prices.
	2023-11-06	+1.56 %
Baxter International (BAX) stock went up by 1.56% following the announcement of new data indicating that Baxter's Sharesource remote patient management digital platform, when used with an automated peritoneal dialysis system, is associated with a 77% reduction in the risk of technique failure in peritoneal dialysis patients, as well as additional data showing that HDx therapy enabled by the Theranova dialyzer can help reduce water consumption by 27% and electricity usage by 17% compared to traditional hemodiafiltration therapy, contributing to the stock's increase.
	2023-11-02	+4.45 %
In the third quarter of 2023, Baxter International Inc. reported better-than-expected financial results, with revenue from continuing operations increasing 3% on a reported basis and 2% on a constant currency basis, leading to a 4.45% increase in the company's stock. The positive performance can be attributed to the completion of strategic initiatives, such as the BioPharma Solutions divestiture and the verticalization of the company's business segments, which have enhanced business performance and increased innovation. The article is about Baxter International (BAX) stock, which went up by 4.45% last night. The reason for the increase in the stock price is not mentioned in the article. The Baxter International (BAX) stock went up by 4.45% due to a sharp rebound in the Indian equity markets following the US Federal Reserve's dovish stance, which boosted investor confidence.
	2023-11-01	+1.11 %
Baxter International (BAX) stock went up by 1.11% following the announcement that Ligand Pharmaceuticals has acquired Tolerance Therapeutics, the company behind TZIELD, the first FDA-approved treatment to delay the onset of Stage 3 type 1 diabetes.
	2023-10-18	+0.69 %
Baxter International's stock went up because Ligand Pharmaceuticals acquired a 13 percent portion of the royalties and milestones owed to Ovid Therapeutics related to the potential approval and commercialization of soticlestat, resulting in Ovid receiving a $30 million payment and extending its cash runway.
	2023-10-17	-0.44 %
Baxter International (BAX) stock went down by 0.44% due to a mixed trading session in the stock market and underperforming compared to some of its competitors.
	2023-10-16	+0.44 %
Baxter International Inc. (BAX) stock went up by 0.44% after the company announced the launch of digital image capture capability for eye exams using its Welch Allyn PanOptic Plus Ophthalmoscope, which helps healthcare professionals examine and diagnose the eye health of patients more efficiently and accurately.
	2023-10-12	-3.15 %
Baxter International (BAX) stock went down by 3.15% last night due to a slump in oil and gas producer Exxon Mobil shares, as well as the success of Danish rival Novo Nordisk's Ozempic in a trial to treat kidney failure, which resulted in a drop in shares of dialysis firms DaVita and Baxter International. Baxter International (BAX) stock went down by 3.15% last night, possibly due to the halt of a study by Novo Nordisk on the effectiveness of its diabetes drug Ozempic, which caused the stock of kidney dialysis providers like Baxter International to tumble.
	2023-10-11	-12.27 %
Baxter International (BAX) stock went down by 12.27% due to the news that Novo Nordisk, a Danish drugmaker, halted its kidney disease treatment trial for Ozempic, causing shares of dialysis services providers DaVita and Fresenius Medical Care to also decline. The article mentions that Baxter International (BAX) stock went down, but it does not provide a specific reason for the decline. The article discusses the decline in Baxter International (BAX) stock by 12.27% and attributes it to the announcement by Novo Nordisk (NOVO) about the success of its diabetes and weight-loss drug Ozempic in treating kidney disease, which led to a drop in the stocks of dialysis machine and insulin pump makers like Baxter International.
	2023-10-06	-1.08 %
Baxter International Inc. (BAX) stock went down by 1.08% due to underperformance compared to its competitors Medtronic PLC, Stryker Corp, and Becton Dickinson & Co, and it closed $21.50 below its 52-week high.
	2023-10-03	-1.53 %
The article announces the appointment of Joel Grade as the new CFO of Baxter International Inc., a global medtech leader. The stock of Baxter International went down by 1.53% last night. The reason for the stock decline is not mentioned in the article.
	2023-10-02	-1.03 %
The article states that Baxter International Inc.'s stock (BAX) experienced a decrease of 1.03% last night, but does not provide a specific reason for the decline.
	2023-09-29	+0.53 %
Baxter International (BAX) stock went up by 0.53% following news that private equity firm Carlyle Group Inc is in exclusive negotiations to acquire a majority stake in two medical device businesses of Medtronic Plc, valued at over $7 billion, as part of Medtronic's effort to streamline its portfolio and focus on higher-growth assets.
	2023-09-27	+0.03 %
The article discusses Ligand Pharmaceuticals' acquisition of assets from Novan, including the rights to the berdazimer gel and NITRICIL technology platform. Baxter International's stock went up because investors are optimistic about Ligand's potential FDA approval for berdazimer gel as an at-home treatment for molluscum contagiosum.
	2023-09-26	-0.48 %
The article announces the appointment of Martine Zimmermann as an independent director on the board of Ligand Pharmaceuticals Incorporated, citing her extensive expertise in development and regulatory affairs in the pharmaceutical industry, which will be valuable as the company builds its portfolio of partnered programs. It does not mention why Baxter International stock went down. The article reports that Baxter International Inc. (BAX) stock went down by 0.48% due to a overall negative day in the stock market. The stock had its fifth consecutive day of losses and closed $20.91 short of its 52-week high. The trading volume was also below its 50-day average volume.
	2023-09-22	-1.08 %
Shares of Baxter International Inc. (BAX) fell 1.08% to $37.70, marking the third consecutive day of losses. The stock underperformed compared to its competitors, and the decline in the overall stock market, with the S&P 500 and Dow Jones Industrial Average also falling.
	2023-09-21	-0.94 %
Baxter International (BAX) stock went down by -0.94% after Ligand Pharmaceuticals Incorporated (LGND) announced that its partner Travere Therapeutics released positive results from its Phase 3 PROTECT Study of FILSPARI in IgA nephropathy (IgAN), showing long-term kidney function preservation and a meaningful difference in estimated glomerular filtration rate (eGFR) compared to the control drug irbesartan. The article discusses the appointment of Michael F. Mahoney, Chairman and CEO of Boston Scientific Corporation, to the Board of Directors of CVS Health Corporation. It does not provide information on why Baxter International (BAX) stock went down.
	2023-09-20	-1.26 %
Baxter International Inc. (BAX) stock went down by 1.26% due to a generally negative trading session in the stock market, with the S&P 500 Index and Dow Jones Industrial Average also falling. The article discusses the stock performance of Edwards Lifesciences Corp (NYSE:EW), noting that despite a daily loss of 0.97% and a 3-month loss of 20.58%, the company posted a relatively high Earnings Per Share (EPS) of 2.26. The article speculates whether the stock is undervalued and provides a comprehensive valuation analysis. It concludes that the stock of Edwards Lifesciences appears to be significantly undervalued, citing factors such as historical trading multiples, past business growth, and future performance estimates. The article also highlights the company's strong financial strength, profitability, and growth. The article discusses the financial standing and potential growth of Edwards Lifesciences Corp (EW), which has recently drawn interest from investors and analysts due to its strong financial performance. The company has received high ranks in financial strength, profitability, growth, and GF value, and is assigned a GuruFocus Score of 97 out of 100, indicating a high potential for outperformance. The article does not provide a specific reason for why Baxter International (BAX) stock went down.
	2023-09-19	+0.59 %
The article is a press release announcing that Baxter International will be hosting a conference call to discuss its third-quarter financial results. The stock of Baxter International went up by 0.59%. The reason for the stock going up is not mentioned in the article. The article discusses the potential for a rise in 8%+ yielding closed-end funds (CEFs) and highlights the Federal Reserve Bank of Chicago's September report indicating a path to a soft landing for the economy. The author suggests that this economic stability could lead to stock prices being undervalued and recommends purchasing blue chip stocks through CEFs like BlackRock Enhanced Equity Dividend Trust (BDJ), which offers an 11% discount to net asset value (NAV) and includes stocks such as Baxter International. However, the author mentions that there is uncertainty regarding whether the Federal Reserve will raise or stabilize interest rates. Overall, the article argues that the current environment is favorable for buying stocks through CEFs like BDJ. The stock of Baxter International Inc. (BAX) went up by 0.59% despite a rough trading session in the stock market, and it outperformed some of its competitors such as Medtronic, Stryker, and Becton Dickinson & Co. The rise in the stock snapped a two-day losing streak, and the trading volume remained slightly below average.
	2023-09-18	-0.9 %
The article announces that Ligand Pharmaceuticals Incorporated has entered into a merger agreement, resulting in its subsidiary becoming a wholly owned subsidiary of Primrose Bio, a private company focused on synthetic biology; as a result, Baxter International (BAX) stock went down -0.9%.
	2023-09-14	+0.1 %
Baxter International (BAX) stock went up by 0.1% due to a positive trading session in the stock market overall, with the S&P 500 Index and the Dow Jones Industrial Average both rising. The stock had its second consecutive day of gains but closed below its 52-week high. Its performance was mixed compared to some of its competitors.
	2023-09-11	+0.08 %
Baxter International (BAX) stock went up by 0.08% after Levi & Korsinsky, LLP notified investors of a class action securities lawsuit that seeks to recover losses on behalf of Baxter investors who were affected by alleged securities fraud between May 25, 2022, and February 8, 2023. The article announces that a class action lawsuit has been filed against Baxter International Inc. for allegedly making misleading statements about its supply chain problems, which led to a decline in the company's stock price. The reason for the recent increase in Baxter International's stock is not mentioned in the article. The article announces a class action lawsuit against Baxter International Inc. alleging that the company made false and misleading statements about its supply chain issues, leading to a decline in the stock price. The reason for the recent slight increase in Baxter International's stock is not mentioned in the article.
	2023-09-08	-0.77 %
Baxter International's stock went down due to the company's failure to meet its earning guidance for the year and supply chain problems that were not properly disclosed to investors. Baxter International Inc. (BAX) stock slid 0.77% due to underperformance compared to its competitors Medtronic PLC (MDT), Stryker Corp. (SYK), and Becton Dickinson & Co. (BDX), and closed $21.72 below its 52-week high.
	2023-09-07	-1.69 %
Baxter International Inc. (NYSE: BAX) stock went down by -1.69% last night. The article does not provide a specific reason for this decline in the stock. The article discusses class action lawsuits filed against Baxter International, Rain Oncology, and Danaher Corporation on behalf of shareholders. Baxter International's stock went down due to the revelation that the company had not gained control over its supply chain problems as previously claimed, leading to unreliable earnings guidance. The article notifies investors of a class action securities lawsuit against Baxter International Inc. The lawsuit alleges securities fraud and claims that the company concealed supply chain problems, leading to materially misleading projected earnings. This may explain why Baxter International's stock price declined by nearly 50% during the Class Period.
	2023-09-06	+1.67 %
The article is about a class action lawsuit against Baxter International Inc. alleging that the company made false and misleading statements about its supply chain problems, resulting in a decline in their stock price. It does not provide information about why the Baxter International stock went up. The article discusses the positive financial stance of Edwards Lifesciences Corp (EW), highlighting its ranks in financial strength, profitability, growth, and momentum. The stock of Edwards Lifesciences Corp has seen a surge of 1.09% recently, and the company is well-positioned for substantial growth in the near future due to its strong financial metrics. However, the article does not provide any specific reasons for why the stock of Baxter International (BAX) went up. The article discusses a notice issued to shareholders of Baxter International Inc. regarding a possible class action lawsuit. The stock of Baxter International went up by 1.67% last night, but the article does not provide a specific reason for this increase.
	2023-09-05	-3.97 %
The article discusses an investigation into claims of securities fraud or unlawful business practices by Baxter International Inc. that may have caused the company's stock to go down. The investigation follows several instances where Baxter had to lower its earnings guidance and faced challenges related to supply chain constraints. The article states that Baxter International (BAX) stock went down by -3.97% last night, and it is being investigated for potential securities fraud or other unlawful business practices by Pomerantz LLP. The stock has faced challenges due to ongoing supply chain issues, increased inflationary pressures, difficulty in accessing critical components, and increased prices of diesel fuel impacting freight expenses. Additionally, the company's decision to spin off certain business units and simplify its operating model has also negatively impacted the stock. Baxter International (BAX) stock went down by 3.97% last night, possibly due to a securities class action lawsuit filed against the company alleging violations of the Securities Exchange Act of 1934 and misrepresentation of supply chain problems.
	2023-09-01
The article states that Baxter International Inc. (BAX) stock went down due to various factors, including lowered earnings guidance, supply chain challenges, global supply chain constraints, and operational changes. A law firm, Pomerantz LLP, is investigating whether Baxter and certain individuals have engaged in securities fraud or other unlawful business practices.
	2023-08-31	-3.26 %
The article discusses Baxter International Inc (BAX) stock, which experienced a 3.26% decline. The decline may be attributed to certain risk factors, including the company's low Altman Z-score and declining operational efficiency, suggesting potential financial distress and underperformance. Investors should be cautious and conduct thorough due diligence before investing in Baxter International. The article notifies investors of a class action securities lawsuit against Baxter International Inc. (BAX) and alleges that the company made false statements and concealed supply chain problems, leading to a decline in stock price. The reason for the stock going down is not explicitly mentioned in the article, but it suggests that the alleged securities fraud and the revelation of the supply chain problems likely had a material negative impact on the company's financial condition, resulting in a decline in the stock price. The article is an alert from the securities litigation law firm Kuznicki Law PLLC, informing shareholders of Baxter International Inc. (NYSE: BAX) that they have until September 11, 2023 to file lead plaintiff applications in a securities class action lawsuit, suggesting that the stock may have gone down due to false and/or misleading statements or the omission of material information by the company.
	2023-08-30	-0.85 %
The article discusses a class action lawsuit filed against Baxter International Inc. (BAX) on behalf of investors who purchased the company's securities between May 25, 2022, and February 8, 2023. The lawsuit alleges that Baxter made materially false and misleading statements about its supply chain problems, which had a negative impact on the company's financial condition. The stock price fell on February 9, 2023, after Baxter revealed that it did not meet its earning guidance for the year due to supply chain headwinds.
	2023-08-29	+1.63 %
The article discusses a notice from The Gross Law Firm regarding Baxter International Inc. and encourages shareholders who purchased shares of BAX during a specific period to contact the firm about possible lead plaintiff appointment, as there are allegations of the company issuing false and misleading statements regarding their supply chain problems and projected earnings, which ultimately led to a significant decline in the company's stock price. The reason for the recent increase in Baxter International's stock is not mentioned in the article. The article announces that Baxter International Inc. will present at a healthcare conference, and the stock went up because of this positive news. The article discusses a class action lawsuit against Baxter International Inc. for allegedly issuing false statements about its supply chain problems, which led to a decline in the company's stock price. The increase in Baxter International's stock last night is not mentioned in the article, so the reason for the increase is not provided.
	2023-08-28	+0.29 %
The article is not about Baxter International's stock going up; it is a reminder for investors about class action lawsuits that have been commenced against BioXcel Therapeutics, Inc. and Seagate Technology Holdings Plc. Furthermore, there is information provided about another class action lawsuit that has been initiated against Baxter International, Inc. for allegedly making false and misleading statements regarding its supply chain problems. The article announces that a class action complaint has been filed against Baxter International Inc. for allegedly violating federal securities laws, and provides information for shareholders to seek compensation for their losses. The reason for Baxter International's stock going up is not mentioned in the article. The article discusses a class-action lawsuit that has been filed against Baxter International Inc. (BAX) and certain officers of the company, alleging violations of federal securities laws. The lawsuit claims that Baxter concealed supply chain problems and misrepresented its ability to maintain a healthy supply chain, leading to misleading earnings projections and a significant decline in the company's stock price. The article also provides information for investors who wish to join the lawsuit. There is no information provided in the article that explains why Baxter International's stock went up by 0.29%.
	2023-08-25	+0.17 %
Shares of Baxter International Inc. (BAX) went up by 0.17% last night, potentially due to a positive trading session in the stock market and the stock's rebound after a two-day losing streak. The article discusses a notice to shareholders of Baxter International Inc. from The Gross Law Firm, stating that shareholders who purchased shares of BAX during a specific period are encouraged to contact the firm regarding potential lead plaintiff appointment. The allegations suggest that the company issued false and misleading statements about its supply chain problems, which had a negative impact on the company's financial condition. The stock price declined by nearly 50% during the class period. The article does not explain why the stock was up 0.17% the previous night.
	2023-08-24	+0.12 %
The article discusses a class action securities lawsuit against Baxter International Inc. (BAX) for alleged securities fraud between May 25, 2022 and February 8, 2023, and provides information for investors to potentially join the lawsuit; the article does not explain the reason why Baxter International's stock went up. The article discusses a class action securities lawsuit filed against Baxter International Inc. (BAX) alleging that the company made false statements and concealed supply chain problems, leading to a decline in the stock price. The reason for the recent increase in the stock is not mentioned in the article. Baxter International Inc. (BAX) stock rose 0.12% amidst a generally rough trading session for the stock market, with the S&P 500 and Dow Jones Industrial Average both falling; the reason for the stock's increase is not provided in the article.
	2023-08-23	-0.48 %
The article discusses Baxter International's announcement of a dividend payment, noting that while the dividend yield is attractive, there are concerns about its sustainability due to the company's lack of profitability and declining earnings per share. The stock may have gone down due to investor concerns about the stability of the dividend and the company's growth potential. Baxter International (BAX) stock went down 0.48% due to underperformance compared to its competitors and a decrease in trading volume. The article discusses a class action lawsuit filed against Baxter International, Inc. for allegedly misleading investors about supply chain problems, which led to a decline in the company's stock price.
	2023-08-22	-1 %
Baxter International (BAX) stock went down 1.0% last night due to the announcement of a leadership transition at Zimmer Biomet Holdings, Inc., where Ivan Tornos was appointed President and CEO, replacing Bryan Hanson. Bernstein Liebhard LLP reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit against Baxter International, Inc. The lawsuit alleges violations of the Securities Exchange Act of 1934, with defendants accused of misrepresenting and concealing supply chain problems that were impacting the company's earnings. The stock price of Baxter International fell over 12% after the company announced lower earnings guidance. The article announces that investors have the opportunity to lead a securities fraud class action lawsuit against Baxter International Inc. The lawsuit alleges that Baxter concealed supply chain problems, causing its projected earnings to be misleading and likely negatively impacting the company's financial condition. The reason for the stock going down is likely due to these allegations and the potential legal consequences for the company.
	2023-08-21	+0.57 %
The article discusses a class action lawsuit filed against Baxter International Inc. for allegedly making false and misleading statements about its business operations and prospects, resulting in a significant drop in the company's stock price. The article does not provide an explanation for why the stock went up. The article discusses the ownership structure of Baxter International Inc. (BAX) and highlights the influence of institutional investors on the stock price. With 88% ownership by institutions, the stock price of Baxter International might be influenced by their trading decisions. The article also mentions that the stock went up by 0.57% the previous night, but does not provide a specific reason for the increase. Baxter International (BAX) stock went up 0.57% because the company announced the appointment of Stephen H. Rusckowski, former CEO of Quest Diagnostics, to its board of directors, adding his deep healthcare industry and public company board experience to enhance the current board expertise.
	2023-08-18	+0.1 %
The article is an investigation into claims of securities fraud or other unlawful business practices by Baxter International Inc. The stock price of Baxter International went up by 0.1%, but the article does not provide information on why the stock went up. The article is about a class action securities lawsuit filed against Baxter International Inc. (NYSE: BAX), alleging securities fraud between May 25, 2022 and February 8, 2023, and investors have until September 11, 2023 to request to be appointed as the lead plaintiff. The lawsuit claims that the company made false statements and concealed supply chain problems, leading to a decline in stock price. The reason for the recent increase in Baxter International's stock is not mentioned in the article. Baxter International Inc. (BAX) stock went up 0.1% last night, but the article does not provide a specific reason for the increase.
	2023-08-17	-0.78 %
The article is about a securities class action lawsuit filed against Baxter International Inc. (BAX) by Kuznicki Law PLLC on behalf of shareholders who purchased the company's securities between May 12, 2022 and February 8, 2023, which may be the reason for the stock going down. The article discusses class action lawsuits against Baxter International, Inc. (BAX), Danaher Corporation (DHR), and Syneos Health, Inc. (SYNH) and explains why the stock prices of these companies went down. Specifically, Baxter International revealed that it had supply chain problems that affected its earnings guidance, Danaher Corporation reported lower revenue growth and reduced revenue forecasts, and Syneos Health disclosed several issues including workforce reductions and inflated financial metrics. The article announces a class action securities lawsuit against Baxter International Inc. The lawsuit alleges that the company made false statements and concealed supply chain problems, which had a negative impact on the company's financial condition. This may be the reason why Baxter International's stock went down.
	2023-08-16	-0.64 %
The Baxter International Inc. (BAX) stock went down by -0.64% last night. The decrease may be attributed to allegations that the company concealed supply chain problems and issued misleading statements about its financial condition, leading to a decline in stock price throughout the class period. The article reports that Baxter International's stock went down by 0.64% due to a generally negative trading session in the stock market and the stock's third consecutive day of losses. The article announces a class-action lawsuit against Baxter International Inc. accusing the company of issuing false and misleading statements about its supply chain problems, which led to a decline in the company's stock price.
	2023-08-15	-1.07 %
The article announces that a class action complaint has been filed against Baxter International Inc. by shareholders, alleging that the company violated federal securities laws by concealing supply chain problems and providing misleading information about its earnings projections, causing the stock price to decline by nearly 50%. The stock price of Baxter International Inc. (BAX) went down by 1.07% last night due to a class action complaint filed against the company, alleging that it violated federal securities laws by concealing supply chain problems and providing misleading earnings projections. Baxter International (BAX) stock went down by -1.07% last night, and this may be due to a class action lawsuit filed against the company alleging that it made false and misleading statements about its supply chain issues, which had a negative impact on the company's financial condition.
	2023-08-14	-0.99 %
Bronstein, Gewirtz & Grossman, LLC, a law firm, has filed a class action lawsuit against Baxter International Inc. for alleged violations of federal securities laws. The lawsuit claims that Baxter concealed supply chain problems and exaggerated its ability to maintain a healthy supply chain, leading to materially misleading projected earnings and a significant decline in the company's stock price. Baxter International Inc. (BAX) stock went down by 0.99% last night, and this decline may be attributed to a class action lawsuit that alleges the company concealed supply chain problems and provided misleading financial projections. Bernstein Liebhard LLP, a law firm, reminds investors of the deadline to file a lead plaintiff motion in a securities class action lawsuit against Baxter International, Inc. The lawsuit alleges violations of the Securities Exchange Act of 1934 due to the company's alleged misrepresentation and concealment of supply chain problems, which resulted in lower earnings guidance. This may explain why Baxter International's stock went down.
	2023-08-11	+0.58 %
The article announces a securities fraud class action lawsuit against Baxter International Inc. (BAX) on behalf of shareholders, alleging that the company issued misleading statements about its supply chain problems, which ultimately led to a decline in the company's stock price. The reason for the recent increase in Baxter International's stock price is not mentioned in the article. Shares of Baxter International Inc. (BAX) went up by 0.58% due to a mixed trading session in the stock market, with the Dow Jones Industrial Average rising 0.30% and the S&P 500 Index falling 0.11%. The article announces a securities fraud class action lawsuit against Baxter International Inc. (BAX) on behalf of shareholders who purchased the stock between May 25, 2022, and February 8, 2023, due to allegations of the company issuing false and misleading statements about its supply chain problems, which had a significant negative impact on its financial condition. The stock price of Baxter International Inc. declined by almost 50% during that period.
	2023-08-10	+0.02 %
The article is about a class action securities lawsuit filed against Baxter International Inc. The lawsuit alleges that the company made false statements regarding its supply chain problems, leading to a decline in stock price. The stock went up last night by 0.02%. The Baxter International (BAX) stock went up by 0.02% last night, and the article is about a securities class action lawsuit filed against the company. The article announces a class action lawsuit on behalf of shareholders of Baxter International Inc. (BAX) and provides information on how to file a lead plaintiff application; it does not mention why the stock went up.
	2023-08-09	+0.49 %
The article discusses a notice to shareholders of Baxter International Inc. regarding a class action lawsuit alleging that the company issued false and misleading statements about its supply chain problems, which resulted in a significant decline in the company's stock price; the article does not explain why the stock went up 0.49%. The article discusses a class action lawsuit against Baxter International Inc. for allegedly issuing false and misleading statements about its supply chain problems, resulting in a decline in stock price. The reason for Baxter International Inc.'s stock going up is not mentioned in the article. The Law Offices of Frank R. Cruz has announced that investors have the opportunity to lead a securities fraud class action lawsuit against Baxter International Inc. The lawsuit alleges that Baxter International concealed supply chain problems and made misleading statements about its financial condition, causing its projected earnings to be materially misleading. As for why the stock went up, this information does not provide any explanation for the stock's recent increase.
	2023-08-08	-1.77 %
The article announces that a class action complaint has been filed against Baxter International Inc. (BAX) alleging that the company violated federal securities laws, and as a result, the stock price declined by nearly 50%. Baxter International Inc. (BAX) stock went down by -1.77% last night due to a class action securities lawsuit filed against the company, alleging securities fraud and false statements regarding the extent of supply chain problems and projected earnings. Baxter International (BAX) stock went down by 1.77% last night, likely due to a securities class action lawsuit filed against the company, alleging violations of the Securities Exchange Act of 1934 related to supply chain problems and earnings guidance.
	2023-08-07	-0.87 %
Baxter International Inc. (BAX) stock went down by -0.87% due to a class action lawsuit alleging that the company made false and misleading statements about supply chain problems and projected earnings, which had a significant negative impact on the company's financial condition. The article is about a class action lawsuit filed against Baxter International Inc. for allegedly making false and misleading statements about the company's supply chain issues, which caused the stock price to fall. Baxter International Inc. (BAX) stock went down by 0.87% due to a class action complaint filed by shareholders alleging that the company violated federal securities laws by concealing supply chain problems and exaggerating its ability to maintain a healthy supply chain, resulting in misleading projected earnings and a material negative impact on the company's financial condition. The article discusses class action lawsuits that have been initiated against BioXcel Therapeutics, Inc., Seagate Technology Holdings Plc, Baxter International, Inc., and Danaher Corporation, which may have impacted the stock prices of these companies, including Baxter International, Inc. (BAX), which saw a decrease in stock price due to the revelation of supply chain problems and unreliable earnings guidance.
	2023-08-04	-0.05 %
Baxter International Inc. (BAX) stock went down due to a securities fraud class action lawsuit that alleges the company made false statements and failed to disclose supply chain problems, leading to a significant decline in the stock price.
	2023-08-03	+0.07 %
The article is about a securities class action lawsuit filed against Baxter International Inc. (BAX) and encourages shareholders to contact the law firm handling the case if they purchased the company's securities during a specific period. The article does not provide any information about why Baxter International's stock went up. The Gross Law Firm has issued a notice to Baxter International Inc. shareholders, encouraging them to contact the firm regarding possible lead plaintiff appointment for a class action lawsuit. The complaint alleges that Baxter International concealed supply chain problems and issued misleading statements about their projected earnings, leading to a decline in their stock price. The article does not provide any information on why Baxter International's stock went up.
	2023-08-02	-2.42 %
The article announces that a class action complaint has been filed against Baxter International Inc. (BAX) for allegedly violating federal securities laws, and it is suggested that the company made false and misleading statements about its supply chain problems, leading to a material negative impact on its financial condition and a decline in stock price. The reason for the stock going down is attributed to the revelation of the true extent of the supply chain problems and the misleading projected earnings. The article discusses a class-action lawsuit filed against Baxter International Inc. (BAX) on behalf of investors who purchased the company's securities between May 25, 2022, and February 8, 2023, alleging that the company made materially false and misleading statements about its business operations, including concealing supply chain issues and giving misleading earnings guidance. The stock went down after the company released its fourth-quarter and full-year 2022 financial results, which revealed that it did not meet its earning guidance due to supply chain headwinds. The article is about a notice to shareholders of Baxter International Inc. regarding a class action lawsuit. The lawsuit alleges that the company made false statements and failed to disclose supply chain problems, which had a negative impact on the company's financial condition. This may be one of the reasons why Baxter International's stock went down.
	2023-08-01	-0.51 %
The article discusses class action lawsuits initiated on behalf of stockholders of Seagate Technology Holdings Plc, Baxter International, Inc., and BioXcel Therapeutics, Inc., with specific allegations made against each company. As for Baxter International, its stock went down due to revelations that the company had not achieved control over its supply chain problems and that its earnings guidance had been unreliable. The article announces that a class action complaint has been filed against Baxter International Inc. (BAX) alleging that the company violated federal securities laws, and the stock price declined by nearly 50% over the Class Period due to the company's concealed supply chain problems and misleading earnings projections. The article announces a class action lawsuit against Baxter International Inc. due to allegations of the company making false and misleading statements about its supply chain problems, resulting in a decline in stock price.
	2023-07-31	-3.79 %
The Baxter International Inc. (BAX) stock went down by 3.79% as a class action lawsuit was filed against the company, alleging that it made false and misleading statements about its supply chain problems, which had a negative impact on its financial condition and stock price. Baxter International (BAX) stock went down by -3.79% because the company is facing a class action securities lawsuit alleging that defendants made false statements and concealed supply chain problems, leading to misleading projected earnings and a material negative impact on the company's financial condition. The article announces that investors have the opportunity to lead a securities fraud class action lawsuit against Baxter International Inc. The lawsuit alleges that the company concealed supply chain problems and made misleading statements about its earnings, which ultimately had a negative impact on its financial condition. The reason for the stock going down may be due to these allegations and the potential legal implications.
	2023-07-28	+3.36 %
Baxter International Inc. (BAX) stock went up 3.36% on a positive trading session overall, likely influenced by the rise in the stock market as a whole, with the S&P 500 and Dow Jones Industrial Average also increasing. The Klein Law Firm has filed a class action complaint on behalf of shareholders of Baxter International Inc., alleging that the company violated federal securities laws by concealing the true extent of its supply chain problems, leading to a decline in stock price. It is unclear why the stock went up 3.36% last night. The article announces that a securities fraud class action lawsuit has been filed against Baxter International Inc. (BAX) on behalf of shareholders who purchased the stock between May 25, 2022 and February 8, 2023, claiming that the company made false and misleading statements about its supply chain problems and projected earnings. The article does not provide information on why Baxter International's stock went up.
	2023-07-27	-7.09 %
On Thursday, shares of Baxter International Inc. (BAX) fell 7.09% to $45.48, breaking its two-day winning streak, and underperformed compared to its competitors such as Medtronic PLC, Stryker Corp, and Becton Dickinson & Co. The overall stock market also experienced a decline, with the S&P 500 Index falling 0.64% and the Dow Jones Industrial Average falling 0.67%. The article discusses a notice to shareholders of Baxter International Inc., stating that shareholders who purchased shares of BAX during the class period are encouraged to contact The Gross Law Firm regarding possible lead plaintiff appointment due to allegations that the company issued false and misleading statements about supply chain problems, resulting in a decline in the company's stock price.
	2023-07-26	+0.31 %
The article discusses a class action lawsuit against Baxter International Inc. (BAX) for allegedly issuing false and misleading statements about its supply chain problems, which caused a decline in the company's stock price by nearly 50%. The article does not provide information about why the stock went up. The article announces that a securities fraud class action lawsuit has been filed against Baxter International Inc. (BAX) by shareholders seeking to recover losses between May 25, 2022, and February 8, 2023, due to alleged false and misleading statements made by the company regarding its supply chain problems and projected earnings, which resulted in a significant decline in the stock price. However, it does not provide any information on why the stock went up 0.31% last night.
	2023-07-24	-0.58 %
Baxter International Inc. (BAX) stock went down by -0.58% as a class action complaint has been filed on behalf of shareholders alleging that the company violated federal securities laws, specifically by concealing supply chain problems and providing misleading earnings projections. The article announces a class action lawsuit against Baxter International Inc. (BAX) on behalf of investors who purchased shares between May 25, 2022, and February 8, 2023, alleging that the company made false statements about its supply chain problems and projected earnings, leading to a decline in the stock price.
	2023-07-21	-1.48 %
The article announces a securities fraud class action lawsuit against Baxter International Inc. (BAX) initiated by Jakubowitz Law on behalf of shareholders who purchased Baxter between May 25, 2022 and February 8, 2023, stating that the company issued false and misleading statements regarding its supply chain problems, which had a negative impact on its financial condition and resulted in a significant decline in its stock price. Therefore, the reason for Baxter International's stock going down is attributed to the alleged misconduct and misleading statements by the company. The article announces a class action securities lawsuit against Baxter International Inc. (BAX) and alleges that the company made false statements and concealed supply chain problems, leading to a decline in the stock price by nearly 50%.
	2023-07-20	+3.01 %
The article notifies investors of a class action securities lawsuit against Baxter International Inc. (BAX) and provides information on how to participate in the lawsuit, but it does not mention why the stock went up. The article discusses a notice from The Gross Law Firm to shareholders of Baxter International Inc., informing them of a possible class action lawsuit and encouraging those who purchased shares of BAX during the specified period to contact the firm. The complaint alleges that Baxter International concealed supply chain problems and misrepresented its ability to maintain a healthy supply chain, leading to misleading projected earnings and a significant decline in the company's stock price. The article does not provide information on why Baxter International's stock went up 3.01% last night.
	2023-07-19	+1.7 %
Baxter International Inc. stock rose by 1.7% in a positive trading session for the stock market, with the S&P 500 and Dow Jones Industrial Average also increasing. The stock outperformed some of its competitors, and the increase in trading volume contributed to its upward trajectory.
	2023-07-18	+1.07 %
The article is about a class action lawsuit that has been filed against Baxter International Inc. (BAX) alleging violations of federal securities laws, and it provides information on how investors can join the case. The article does not provide any information about why the stock went up.
	2023-07-17	-0.66 %
The article discusses an investigation into Baxter International Inc. (BAX) regarding potential securities fraud or unlawful business practices. The stock has experienced significant declines due to ongoing supply chain challenges, global supply chain constraints, and a spin-off of business units.
	2023-07-14	+0.3 %
The article announces that a class action lawsuit has been filed against Baxter International Inc. (BAX) and encourages investors to join the lawsuit. The stock of Baxter International went up by 0.3% last night for unknown reasons. The article announces that a securities class action lawsuit has been filed against Baxter International, Inc. for alleged violations of the Securities Exchange Act of 1934 during the period between May 25, 2022, and February 8, 2023, and discusses the impact on the company's stock price. The article does not provide information on why Baxter International's stock went up 0.3% last night.
	2023-07-13	+0.73 %
The article states that Baxter International's stock went up by 0.73% last night, however, it does not provide any specific reasons for the increase. A class action lawsuit has been filed against Baxter International Inc. regarding false and misleading statements about the company's business, operations, and prospects, which caused the stock price to go up. Investors who purchased Baxter securities during the specified period may be entitled to compensation. The Rosen Law Firm is representing investors in this lawsuit and encourages affected individuals to join the class action.
	2023-07-12	+0.76 %
The Oakmark Fund highlights Baxter International Inc. as a strong stock pick, citing the company's leading scale, stable demand for its products, and the potential for higher margins in the future despite temporary challenges from inflation, semiconductor shortages, and the Covid-19 pandemic. The article discusses a class action lawsuit against Baxter International Inc. for allegedly making false and misleading statements about the extent of its supply chain problems, which resulted in a significant decline in the company's stock price. The stock went up 0.76% last night, but the article does not provide a specific reason for the increase.
	2023-07-05	+1.03 %
The article discusses the growth trends and forecasts for the Pharmaceutical Contract Manufacturing Organization (CMO) market, highlighting factors such as the rising demand for generic medicines and biologics, consolidation of CMOs to enhance profitability, outsourcing to countries like China, India, and Japan due to cost advantages, and the impact of the COVID-19 pandemic on the market. It does not specifically mention why Baxter International (BAX) stock went up by 1.03% the previous night.
	2023-06-29	-0.84 %
Baxter International stock (BAX) went down by -0.84% last night, but the article does not provide a specific reason for the decrease. The article announces the launch of Baxter International's new Hillrom Progressa+ bed for the ICU, which is designed to make it easier for nurses to care for patients and support patient recovery, and the stock of Baxter International went down because the article does not provide any information regarding factors that may have influenced the stock price.
	2023-06-26	-0.73 %
Law firm Vincent Wong has started an investigation into Baxter International and certain officers and directors for potential securities fraud, following claims the healthcare company misled investors about the true nature and severity of its supply chain problems. This could be a reason why Baxter International's stock went down by 0.73% last night. Baxter International stock (BAX) was down 0.73% last night; the company has published its 2022 Corporate Responsibility Report that outlines its 2030 Corporate Responsibility Commitment and Goals, which are designed to create a sustainable and responsible business model and address stakeholder priorities, however, this does not appear to have affected the stock.
	2023-06-23	-0.46 %
Baxter International (BAX) stock went down -0.46% due to an ongoing investigation into potential securities fraud allegations that claim Baxter misrepresented and concealed the severity of supply chain problems that impacted the company's expected earnings.
	2023-06-22	+0.91 %
The article reports an investigation by Levi & Korsinsky into possible securities fraud violations by officers of Baxter International, whose stock went up 0.91% last night. Baxter International Inc. stock rose 0.91% due to a mixed trading session and outperformed some of its competitors.
	2023-06-21	-0.22 %
The Gross Law Firm is investigating potential securities fraud claims against Baxter International due to recent announcements suggesting that the company materially misrepresented and/or concealed the true nature and severity of supply chain problems, leading to a loss on BAX investment. The article does not provide a clear reason for why Baxter International's stock went down. Baxter International's stock went down due to the announcement of potential securities fraud claims by The Gross Law Firm, claiming that Baxter concealed the severity of supply chain problems that impacted the company's financial health and earnings.
	2023-06-20	-0.93 %
The Klein Law Firm is investigating allegations that Baxter International, a multi-national healthcare company, violated federal securities laws by materially misrepresenting and/or concealing the true nature and severity of supply chain problems it was encountering and the impact they were having on the company's current and expected earnings, which caused its stock to go down by -0.93%.
	2023-06-16	+2.02 %
Baxter International (BAX) stock went up 2.02% due to the company's second consecutive day of gains, outperforming its competitors Medtronic, Stryker Corp, and Becton Dickinson & Co, as trading volume eclipsed its 50-day average volume.
	2023-06-13	+1.78 %
The Klein Law Firm is investigating allegations of securities fraud violations by officers of Baxter International Inc., a multinational healthcare company primarily focused on products designed to treat kidney disease and other chronic and acute medical conditions, which may have caused the company's stock to go up by 1.78%. The article notifies investors that Levi & Korsinsky has commenced an investigation of Baxter International Inc. concerning possible violations of federal securities laws, and therefore the increase in stock price cannot be attributed to any positive news about the company.
	2023-06-12	+1.76 %
Baxter International's stock went up 1.76% due to a positive trading session in the stock market, with the S&P 500 and Dow Jones Industrial Average rising, and it outperformed some of its competitors such as Stryker Corp. and Becton Dickinson & Co. Baxter International's projected fair value suggests that the stock is potentially 38% undervalued, leading to a 1.76% increase in the stock price, with the company using a two-stage Discounted Cash Flow (DCF) model to value the stock.
	2023-06-09	+1.52 %
The article is about Rite Aid announcing Thomas Sabatino as its new Executive Vice President and Chief Legal Officer to support the company's growth strategy to provide whole health for life to its customers, and therefore it is not related to Baxter International stock going up.

1
500 / page